Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein

Journal of Virology

Volumn 86, Issue 13, 2012, Pages 7136-7145

  Irie, Takashi ^a   Kiyotani, Katsuhiro ^a   Igarashi, Tomoki ^a   Yoshida, Asuka ^a   Sakaguchi, Takemasa ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON REGULATORY FACTOR 3; PROTEIN MDA5; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN V;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; CYTOKINE RELEASE; EMBRYO; FETUS; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; INNATE IMMUNITY; MEASLES VIRUS; MOLECULAR INTERACTION; MOUSE; NEWBORN; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SENDAI VIRUS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VIRUS VIRULENCE;

ANIMALS; DEAD-BOX RNA HELICASES; IMMUNE EVASION; INTERFERON REGULATORY FACTOR-3; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOPROTEINS; SENDAI VIRUS; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRULENCE FACTORS;

MEASLES VIRUS; MUMPS VIRUS; MUS; NEWCASTLE DISEASE VIRUS; NIPAH VIRUS; PARAMYXOVIRIDAE; SENDAI VIRUS;

EID: 84864118573     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06705-11     Document Type: Article

References (52)

1. Andrejeva J, et al. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFNbeta promoter. Proc. Natl. Acad. Sci. U. S. A. 101:17264 -17269.
2. Cadd T, et al. 1996. The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J. Virol. 70:5067-5074.
3. Childs K, et al. 2007. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359:190 -200.
4. Childs KS, Andrejeva J, Randall RE, Goodbourn S. 2009. Mechanism of mda-5 inhibition by paramyxovirus V proteins. J. Virol. 83:1465-1473.
5. Curran J, Boeck R, Kolakofsky D. 1991. The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J. 10:3079 -3085.
6. Curran J, Marq JB, Kolakofsky D. 1992. The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. Virology 189:647- 656.
7. Fukuhara N, Huang C, Kiyotani K, Yoshida T, Sakaguchi T. 2002. Mutational analysis of the Sendai virus V protein: importance of the conserved residues for Zn binding, virus pathogenesis, and efficient RNA editing. Virology 299:172-181.
8. Garcin D, Latorre P, Kolakofsky D. 1999. Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J. Virol. 73:6559-6565.
9. Gitlin L, et al. 2010. Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo. PLoS Pathog. 6:e1000734. doi:10.1371/journal.ppat.1000734.
10. Gotoh B, et al. 1999. Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett. 459:205-210.
11. Huang C, et al. 2000. Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis. J. Virol. 74:7834 -7841.
12. Irie T, Inoue M, Sakaguchi T. 2010. Significance of the YLDL motif in the Mprotein and Alix/AIP1 for Sendai virus budding in the context of virus infection. Virology 405:334 -341.
13. Irie T, Nagata N, Igarashi T, Okamoto I, Sakaguchi T. 2010. Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses. PLoS One 5:e10719. doi:10.1371/journal.pone.0010719.
14. Irie T, Nagata N, Yoshida T, Sakaguchi T. 2008. Paramyxovirus Sendai virus C proteins are essential for maintenance of negative-sense RNA genome in virus particles. Virology 374:495-505.
15. Irie T, Nagata N, Yoshida T, Sakaguchi T. 2008. Recruitment of Alix/AIP1 to the plasma membrane by Sendai virus C protein facilitates budding of virus-like particles. Virology 371:108 -120.
16. Irie T, Shimazu Y, Yoshida T, Sakaguchi T. 2007. The YLDL sequence within Sendai virusMprotein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein. J. Virol. 81: 2263-2273.
17. Kato A, Kiyotani K, Sakai Y, Yoshida T, Nagai Y. 1997. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16:578 -587.
18. Kato A, et al. 1997. Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J. Virol. 71:7266 -7272.
19. Kato H, et al. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19 -28.
20. Kato H, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
21. Kitagawa Y, et al. 2011. A tryptophan-rich motif in the human parainfluenza virus type 2 V protein is critical for the blockade of Toll-like receptor 7 (TLR7)- and TLR9-dependent signaling. J. Virol. 85:4606-4611.
22. Kiyotani K, Sakaguchi T, Fujii Y, Yoshida T. 2001. Attenuation of a field Sendai virus isolate through egg-passages is associated with an impediment of viral genome replication in mouse respiratory cells. Arch. Virol. 146:893-908.
23. Kiyotani K, Sakaguchi T, Kato A, Nagai Y, Yoshida T. 2007. Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice. Virology 359:82-91.
24. Kiyotani K, Takao S, Sakaguchi T, Yoshida T. 1990. Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity. Virology 177:65-74.
25. Komatsu T, Takeuchi K, Gotoh B. 2007. Bovine parainfluenza virus type 3 accessory proteins that suppress beta interferon production. Microbes Infect. 9:954 -962.
26. Koyama AH, Irie H, Kato A, Nagai Y, Adachi A. 2003. Virus multiplication and induction of apoptosis by Sendai virus: role of the C proteins. Microbes Infect. 5:373-378.
27. Lamb RA, Parks GD. 2006. Paramyxoviridae: the viruses and their replication, p 1449-1496. In Knipe DM, et al. (ed), Fields virology, 5th ed, vol 1. Lippincott Williams & Wilkins, Philadelphia, PA.
28. Lin Y, et al. 2007. Inhibition of interleukin-6 expression by the V protein of parainfluenza virus 5. Virology 368:262-272.
29. Lu LL, Puri M, Horvath CM, Sen GC. 2008. Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1. J. Biol. Chem. 283:14269- 14276.
30. Melchjorsen J, et al. 2005. Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-typespecific manner. J. Virol. 79:12944 -12951.
31. Nagai Y. 1999. Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding. Rev. Med. Virol. 9:83-99.
32. Nagai Y, Takakura A, Irie T, Yonemitsu Y, Gotoh B. 2011. Sendai virus: evolution from mouse pathogen to a state-of-the-art tool in virus research and biotechnology, p 115-173. In Samal SK (ed), The biology of paramyxoviruses. Caister Academic Press, Norfolk, United Kingdom.
33. Nakatsu Y, et al. 2008. Measles virus circumvents the host interferon response by different actions of the C and V proteins. J. Virol. 82:8296- 8306.
34. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene 108:193- 199.
35. Pfaller CK, Conzelmann KK. 2008. Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction. J. Virol. 82:12365-12373.
36. Sakaguchi T, et al. 2011. Analysis of interaction of Sendai virus V protein and melanoma differentiation-associated gene 5. Microbiol. Immunol. 55:760 -767.
37. Sakaguchi T, Kato A, Kiyotani K, Yoshida T, Nagai Y. 2008. Studies on the paramyxovirus accessory genes by reverse genetics in the Sendai virusmouse system. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 84:439-451.
38. Sakaguchi T, et al. 2005. AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding. J. Virol. 79:8933- 8941.
39. Schuhmann KM, Pfaller CK, Conzelmann KK. 2011. The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity. J. Virol. 85:3162-3171.
40. Shaw ML, Cardenas WB, Zamarin D, Palese P, Basler CF. 2005. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and Toll-like receptor 3-triggered signaling pathways. J. Virol. 79: 6078-6088.
41. Sugahara F, et al. 2004. Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein. Virology 325:1-10.
42. Takaki H, et al. 2011. Strain-to-strain difference of V protein of measles virus affects MDA5-mediated IFN-beta-inducing potential. Mol. Immunol. 48:497-504.
43. Takeuchi K, Komatsu T, Kitagawa Y, Sada K, Gotoh B. 2008. Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. J. Virol. 82:10102- 10110.
44. Takeuchi K, et al. 2002. Recombinant wild-type and Edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity. J. Virol. 76:4891- 4900.
45. Tapparel C, et al. 1997. Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins. J. Virol. 71:9588 -9599.
46. Thomas SM, Lamb RA, Paterson RG. 1988. Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell 54:891-902.
47. Vidal S, Curran J, Kolakofsky D. 1990. Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. J. Virol. 64:239 -246.
48. Yamamoto M, et al. 2002. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169:6668-6672.
49. Ye J, Maniatis T. 2011. Negative regulation of interferon-beta gene expression during acute and persistent virus infections. PLoS One 6:e20681. doi:10.1371/journal.pone.0020681.
50. Yoneyama M, et al. 2005. Shared and unique functions of the DExD/Hbox helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175:2851-2858.
51. Yoneyama M, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730 -737.
52. Yount JS, Gitlin L, Moran TM, Lopez CB. 2008. MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai virus defective interfering particles. J. Immunol. 180:4910-4918.